MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers.

Alhalabi O, Chen J, Zhang Y, Lu Y, Wang Q, Ramachandran S, Tidwell RS, Han G, Yan X, Meng J, Wang R, Hoang AG, Wang WL, Song J, Lopez L, Andreev-Drakhlin A, Siefker-Radtke A, Zhang X, Benedict WF, Shah AY, Wang J, Msaouel P, Zhang M, Guo CC, Czerniak B, Behrens C, Soto L, Papadimitrakopoulou V, Lewis J, Rinsurongkawong W, Rinsurongkawong V, Lee J, Roth J, Swisher S, Wistuba I, Heymach J, Wang J, Campbell MT, Efstathiou E, Titus M, Logothetis CJ, Ho TH, Zhang J, Wang L, Gao J

Open source

DOI: 10.1038/s41467-022-29397-z
Published: 2022 Apr 4
Container: Nature communications
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41467-022-29397-z,
  title = {MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers.},
  author = {Alhalabi O and Chen J and Zhang Y and Lu Y and Wang Q and Ramachandran S and Tidwell RS and Han G and Yan X and Meng J and Wang R and Hoang AG and Wang WL and Song J and Lopez L and Andreev-Drakhlin A and Siefker-Radtke A and Zhang X and Benedict WF and Shah AY and Wang J and Msaouel P and Zhang M and Guo CC and Czerniak B and Behrens C and Soto L and Papadimitrakopoulou V and Lewis J and Rinsurongkawong W and Rinsurongkawong V and Lee J and Roth J and Swisher S and Wistuba I and Heymach J and Wang J and Campbell MT and Efstathiou E and Titus M and Logothetis CJ and Ho TH and Zhang J and Wang L and Gao J},
  year = {2022},
  journal = {Nature communications},
  doi = {10.1038/s41467-022-29397-z},
  url = {https://doi.org/10.1038/s41467-022-29397-z}
}

RIS

TY  - JOUR
TI  - MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers.
AU  - Alhalabi O
AU  - Chen J
AU  - Zhang Y
AU  - Lu Y
AU  - Wang Q
AU  - Ramachandran S
AU  - Tidwell RS
AU  - Han G
AU  - Yan X
AU  - Meng J
AU  - Wang R
AU  - Hoang AG
AU  - Wang WL
AU  - Song J
AU  - Lopez L
AU  - Andreev-Drakhlin A
AU  - Siefker-Radtke A
AU  - Zhang X
AU  - Benedict WF
AU  - Shah AY
AU  - Wang J
AU  - Msaouel P
AU  - Zhang M
AU  - Guo CC
AU  - Czerniak B
AU  - Behrens C
AU  - Soto L
AU  - Papadimitrakopoulou V
AU  - Lewis J
AU  - Rinsurongkawong W
AU  - Rinsurongkawong V
AU  - Lee J
AU  - Roth J
AU  - Swisher S
AU  - Wistuba I
AU  - Heymach J
AU  - Wang J
AU  - Campbell MT
AU  - Efstathiou E
AU  - Titus M
AU  - Logothetis CJ
AU  - Ho TH
AU  - Zhang J
AU  - Wang L
AU  - Gao J
PY  - 2022
JO  - Nature communications
DO  - 10.1038/s41467-022-29397-z
UR  - https://doi.org/10.1038/s41467-022-29397-z
ER  -

APA

O, A., J, C., Y, Z., Y, L., Q, W., S, R., RS, T., G, H., X, Y., J, M., R, W., AG, H., WL, W., J, S., L, L., A, A., A, S., X, Z., WF, B., AY, S., J, W., P, M., M, Z., CC, G., B, C., C, B., L, S., V, P., J, L., W, R., V, R., J, L., J, R., S, S., I, W., J, H., J, W., MT, C., E, E., M, T., CJ, L., TH, H., J, Z., L, W., & J, G. (2022). MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers.. Nature communications. https://doi.org/10.1038/s41467-022-29397-z

Source records

pubmed · retrieved 2026-09-26T18:24:47.590Z